Biologics Quality Control Testing

ABOUT US

PathoQuest, a spin-out of Institut Pasteur Paris, is a genomics expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.

The NGS-based technology the company has developed is used for:

• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GMP level

PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.

LATEST NEWS

PathoQuest to Participate in CAACB Summer Workshop – Boston, USA| 20-21 July2022

PathoQuest to Participate in CAACB Summer Workshop – Boston, USA| 20-21 July2022

High-throughput sequencing (HTSeq) is of high interest to biopharmaceutical
manufacturers as seen from recent survey results indicating that 81% of CAACB member companies are
currently using or exploring the use of HTSeq for viral safety and the remaining 19% expect to do so in the
future. Despite this significant interest, practical experience in the implementation of HTSeq is not widely
available. To address this gap, we are looking for presentations and case studies sharing practical experiences
with implementing HTSeq for a range of applications.

read more
w

Let’s Start Something New

Welcome to PathoQuest!

EnglishFrenchGermanSpanish